Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 544 of 5804
-
Magic mushroom therapy targets Cancer-Related depression
Symptom relief Recruiting nowTo learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug vs. brain stimulation: which stops suicidal thoughts faster?
Symptom relief CompletedThis study is a multicenter, randomized, non-inferiority, parallel-group clinical trial designed to evaluate the efficacy and safety of esketamine compared with electroconvulsive therapy (ECT) in the treatment of suicidal ideation during depressive episodes in patients with mood …
Phase: NA • Sponsor: Capital Medical University • Aim: Symptom relief
Last updated Jun 26, 2026 13:46 UTC
-
Could freezing breast cancer replace the knife? new trial aims to find out
Disease control Recruiting nowExpand the current evidence base regarding percutaneous cryoablation of early-stage, low-risk breast tumors, integrated into the standard therapeutic pathway with well-defined follow-up data, as well as data on quality of life. Demonstrate, therefore, that the use of percutaneous…
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo therapy shows promise for shrinking lung tumors before surgery
Disease control OngoingThis study aimed to evaluate the efficacy and safety of Toripalimab injection (js001) combined with SBRT radiotherapy and neoadjuvant therapy with or without chemotherapy for operable or potentially operable stage IIa to IIIb NSCLC
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a simple blood test finally diagnose TB in kids?
Diagnosis Recruiting nowPediatric tuberculosis (TB) continues to pose diagnostic challenges in low- and middle-income countries with high rates of TB disease, due to the well-described impact of paucibacillary disease in children, and current TB culture and polymerase-chain reaction tests are of limited…
Sponsor: Tulane University • Aim: Diagnosis
Last updated Jun 26, 2026 13:32 UTC
-
New hope for scleroderma lung disease: major trial underway
Disease control Recruiting nowThe goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sc…
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug shows promise for tough lymphomas in early trial
Disease control OngoingPrimary Objective To evaluate the preliminary efficacy of Purinostat Mesylate for Injection in patients with relapsed or refractory Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL). Secondary Objectives 1. To evaluate the safety and tolerability of Purinos…
Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New trial tests if early surgery saves lives in aortic dissection
Disease control Recruiting nowThe goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with …
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can plasma transfusion and blood filtering save lives in leptospirosis?
Disease control Recruiting nowThe goal of this clinical trial is to learn if complement factor I (CFI) works to predict development of complications in participants with leptospirosis. It will also learn if plasma transfusion, hemoperfusion, and extracorporeal membrane oxygenation works to treat participants …
Phase: PHASE2 • Sponsor: National Kidney and Transplant Institute, Philippines • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Triple threat: new combo therapy targets rare rectal cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if PD-1 monoclonal antibody combined with radical chemoradiotherapy works to treat rectal squamous cell carcinoma (rSCC). lt will also learn about the safety of the regime. The main questions it aims to answer are: Does PD-1 monoclonal…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can mindfulness and brain scans lift teen depression?
Symptom relief Recruiting nowIn the United States, adolescents experience alarmingly high rates of major depression, and gold-standard treatments are only effective for approximately half of patients. Rumination may be a promising treatment target, as it is well-characterized at the neural level and contribu…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could a statin right after a stroke stop a second one?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.
Phase: PHASE3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stroke survivors: which statin combo cuts recurrence best?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.
Phase: PHASE3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Could less be more? major trial tests shorter drug regimen for myeloma
Disease control Recruiting nowCurrently, daratumumab or isatuximab are given continuously (non-stop), along side lenalidomide, and dexamethasone as part of multiple myeloma treatment. are given continuously (non-stop). Recent observations suggest that stopping daratumumab or isatuximb after about a year and a…
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug trial offers hope for rare brain disease in boys
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION356.
Phase: PHASE1 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail aims to outperform standard lung cancer therapy
Disease control Recruiting nowNon-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival prospects for metastatic disease. The purpose of this study is to evaluate the optimized dose, adverse events, and efficacy of livmoniplimab in combination wi…
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a needle replace a machine? new study aims to simplify lifesaving iTTP treatment
Disease control Recruiting nowImmune thrombotic thrombocytopenic purpura (iTTP) is caused by a severe, autoantibody-mediated deficiency of ADAMTS13 leading to an accumulation of ultra-large von Willebrand factor multimers in plasma and finally to microthrombi in blood vessels. The current standard of care of …
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental CAR-T therapy takes on progressive MS
Disease control Recruiting nowA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug targets Hard-to-Treat breast cancers
Disease control CompletedThe primary purpose of the Dose Optimization (Part 1) of this study is to assess the safety and tolerability of BB-1701 and to determine the recommended dose (RD) of BB-1701 for Dose Expansion (Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor act…
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug targets 13 cancers in major trial
Disease control Recruiting nowThis study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcino…
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC